Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs KERNX Health
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · KERNX Health: Check date not recorded
vs
Verdict56/ 100
Grade C · #415KERNX Health
Washington DC telehealth platform with month-to-month compounded GLP-1 plans, undermined by a pricing page that contradicts itself on whether consultations cost extra.
Visit KERNX HealthThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 56/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. KERNX Health still earns its place — buyers who want month-to-month billing with no prepayment and will budget for the separate per-visit fee.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results60
92
Real-world results60
97Price honesty40
97
Price honesty40
96Prescriber access70
96
Prescriber access70
88Formulary choice40
88
Formulary choice40
95Cancellation fairness80
95
Cancellation fairness80
93Member support50
93
Member support50
Price, coverage & features
| Metric | CoreAge Rx | KERNX Health |
|---|---|---|
| Verdict Score | 94/100 | 56/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $249/mo standard |
| Tirzepatide | $149/mo | $299/mo standard |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
KERNX Health
What we like
- Plan pricing is published openly before any intake or account creation
- Month-to-month billing with no long-term contract and no multi-month prepayment
- Billing begins only after a licensed provider approves treatment
- Cancel before the next renewal date from the account or by email, which stops all future charges
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved finished products and have not been reviewed for safety, effectiveness or quality
- The pricing page contradicts itself: one section says there are no separate consultation charges, another says $25-$60 applies per visit
- That consultation fee is charged whether or not a prescription is issued
- The $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299, roughly double
- No compounding pharmacy is named, only described as an FDA-registered 503B facility
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Buyers who want month-to-month billing with no prepayment and will budget for the separate per-visit fee.
Visit KERNX Health Read the full KERNX Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for KERNX Health does the reverse.
More on CoreAge Rx
More on KERNX Health
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.